CERO THERAPEUTICS HOLDINGS, INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
CERO THERAPEUTICS HOLDINGS, INC. (CERO) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 4.09 million shares for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-19.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2021-11-19
- CERO THERAPEUTICS HOLDINGS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 4.09M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 4 month |
|---|---|---|
| 2021-09-30 | 4.09M shares 10-Q · filed 2021-11-19 | 4.09M shares 10-Q · filed 2021-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |